DD
David Dai UBS Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Syndax Pharmaceuticals
SNDX
$1.47B
| $17.04 | $35 |
105%
upside
| Buy |
15 Jul ‘25
1 month ago |
|
2
Nurix Therapeutics
NRIX
$758M
| $9.91 | $26 |
162%
upside
| Buy |
10 Jul ‘25
1 month ago |
|
3
Summit Therapeutics
SMMT
$19.3B
| $25.98 | $30 |
15%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
4
Iovance Biotherapeutics
IOVA
$901M
| $2.49 | $2 |
20%
downside
| Neutral |
16 May ‘25
3 months ago |
|
5
Cullinan Oncology
CGEM
$413M
| $6.99 | $24 |
243%
upside
| Buy |
12 May ‘25
3 months ago |
|
6
Nuvalent
NUVL
$5.83B
| $80.89 | $100 |
24%
upside
| Buy |
14 Mar ‘25
5 months ago |
|
7
Kura Oncology
KURA
$713M
| $8.22 | $14 |
70%
upside
| Buy |
6 Mar ‘25
6 months ago |
|
8
Immunocore
IMCR
$1.87B
| $37.20 | $24 |
35%
downside
| Sell |
24 Oct ‘24
10 months ago |
|
9
Perspective Therapeutics
CATX
$257M
| $3.46 | $20 |
478%
upside
| Buy |
24 Oct ‘24
10 months ago |
|
10
Merus
MRUS
$5.1B
| $67.47 | $72 |
7%
upside
| Buy |
24 Oct ‘24
10 months ago |
|
11
Janux Therapeutics
JANX
$1.44B
| $23.98 | $69 |
188%
upside
| Buy |
24 Oct ‘24
10 months ago |
|
12
IDEAYA Biosciences
IDYA
$2.38B
| $27.16 | $50 |
84%
upside
| Buy |
24 Oct ‘24
10 months ago |
|
13
CG Oncology
CGON
$2.52B
| $33.07 | $60 |
81%
upside
| Buy |
24 Oct ‘24
10 months ago |
|
14
Adicet Bio
ACET
$60M
| $0.7203 | $28 |
3,787%
upside
| Outperform |
31 Mar ‘22
3 years ago |
|
15
MacroGenics
MGNX
$126M
| $2 | $40 |
1,900%
upside
| Outperform |
4 Feb ‘22
3 years ago |
|
16
Nkarta
NKTX
$161M
| $2.26 | $50 |
2,112%
upside
| Outperform |
18 Nov ‘21
3 years ago |
|
17
JD.com
JD
$44.6B
| $31.45 | $52 |
65%
upside
| Outperform |
17 Mar ‘20
5 years ago |
|